A new study has found that reduced glutathione, when combined with entecavir, significantly improves liver function, reduces fibrosis, and enhances HBV-DNA clearance in chronic hepatitis B patients.

To tackle the ongoing high burden of hepatitis C virus (HCV) infections among people who inject drugs (PWID), WHO has set a specific incidence target among PWID of no more than two new infections per ...

ETH Zurich researchers have investigated how tiny gas bubbles can deliver drugs into cells in a targeted manner using ...